Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 17Radiotherapy 13Paclitaxel 13Cisplatin 9Vinorelbine 5Pemetrexed 5Gemcitabine 5Docetaxel 5Mastectomy, Segmental 4Gefitinib 4Bevacizumab 4Taxes 3Radiation 3Etoposide 3ceritinib 2shark cartilage extract 1pembrolizumab 1pegfilgrastim 1lorlatinib 1lazertinib 1efaproxiral 1Vindesine 1Vinblastine 1Tirapazamine 1Therapeutics 1Thalidomide 1Surgical Procedures, Operative 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma of Lung × Tirapazamine × Clear all
NCT00006484 2013-06-24

Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Completed
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡